Vorasidenib Clinical Trials
5 recruitingDrug
Phase 32Phase 11
Showing 1–5 of 5 trials
Recruiting
Phase 3
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Astrocytoma, IDH-Mutant, Grade 3
Alliance for Clinical Trials in Oncology408 enrolled75 locationsNCT07215910
Recruiting
Phase 3
Vorasidenib Maintenance for IDH Mutant Astrocytoma
IDH-mutant Grade 2 or 3 Astrocytoma
European Organisation for Research and Treatment of Cancer - EORTC468 enrolled33 locationsNCT06809322
Recruiting
Patient Voice in the Treatment of Low-grade Gliomas: Use of Patient-reported Outcomes, Vorasidenib and Radiotherapy Compared
GliomaGlioma of BrainLow Grade Glioma of Brain+2 more
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta90 enrolled1 locationNCT07547163
Recruiting
Phase 1
A Drug-drug Interaction Study of Vorasidenib and a Combined Oral Contraceptive in Healthy Female Participants
Healthy Adult Female Participants
Institut de Recherches Internationales Servier (I.R.I.S.)28 enrolled1 locationNCT07235774
Recruiting
Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse Glioma
Glioma
iOMEDICO AG150 enrolled1 locationNCT07240662